लोड हो रहा है...
Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins
Genome editing in human cells with targeted nucleases now enables diverse experimental and therapeutic genome engineering applications, but extension to primary human B cells remains limited. Here we report a method for targeted genetic engineering in primary human B cells, utilizing electroporation...
में बचाया:
| में प्रकाशित: | J Immunol Methods |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2018
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6124898/ https://ncbi.nlm.nih.gov/pubmed/29614266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2018.03.009 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|